Poland – Various medicinal products – Supply of medicinal products used in drug programs and cancer chemotherapy for the needs of the Clinics of USK-2 PUM in Szczecin
1. The subject matter of the contract is the supply of medicinal products used in drug programs and cancer chemotherapy for the needs of the Clinics of USK-2 PUM in Szczecin, hereinafter referred to as “products. 2. The description of the subject matter of the contract and the estimated quanti
Opportunity description
1. The subject matter of the contract is the supply of medicinal products used in drug programs and cancer chemotherapy for the needs of the Clinics of USK-2 PUM in Szczecin, hereinafter referred to as “products. 2. The description of the subject matter of the contract and the estimated quantities of the products are included in the unit price form (Annex 2 to the SWZ, hereinafter also referred to as the FCJ). This form must be submitted together with the tender form (Annex 1 to the SWZ, hereinafter also referred to as the “FO”). 3. The Contracting Authority requires the offering of: a) medicinal products in accordance with the Act of 6 September 2001, Pharmaceutical Law (Journal of Laws 2001.126.1381, as amended), placed on the market and put into use in the territory of the Republic of Poland in accordance with the applicable regulations for tasks Nos. 1-15. 4. The Contracting Authority requires that the medicinal products offered be included, as of the tender submission date, in the current Notice of the Minister of Health concerning the list of reimbursed medicines: - Annex B, medicines available under a drug program - applies to tasks: 1, 2, 4, 5, 6, 7, 8, 9, 10, 11 - Annex C, medicines available under chemotherapy - applies to tasks: 3, 12, 13, 14, 15. Failure to meet the condition described in points Nos. 2 and 3 will result in rejection of the tender. 5. The Contracting Authority requires that the shelf life of all products offered be at least 12 months, calculated from the date of delivery to the Contracting Authority's registered office. 6. The quantities of the assortment constituting the subject matter of the contract, specified in the annex to the agreement (TASKS NOS. 1-15), are estimated values used to correctly calculate the tender price, compare tenders, and select the most advantageous tender. The quantity of the assortment ordered during performance of the agreement may be decreased or increased within individual assortment items depending on the Contracting Authority's actual needs, provided that the value of the tender and, consequently, the agreement of the selected Contractor is not exceeded. The Contracting Authority has the right not to purchase the full quantity and assortment specified in the agreement. In such a situation, the Contractors will not be entitled to any claims. The Contracting Authority has the right not to perform the full subject matter of the agreement. Patients are qualified for drug programs on the basis of criteria established by the Ministry of Health and the NFZ. The Contracting Authority has no real influence over them and therefore cannot declare a minimum level of contract performance. 7. Pursuant to Article 30(2) of the PZP Act, the Contracting Authority awards the contract in parts, each of which constitutes the subject matter of a separate procedure. 8. The contract consists of 15 tasks, the detailed description of which is included in Annex 2, FCJ. 9. The Contracting Authority does not permit the submission of variant tenders. Procedure: open. Estimated value: 29,325,247.93 PLN. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.